Citigroup
HSTO

Citigroup’s Histogen Inc. Common Stock HSTO Stock Holding History

Citigroup’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50
Closed -$3K – 7877
2019
Q2 		$3K Sell
50
-3
-6% -$521 ﹤0.01% 7590
2019
Q1 		$11K Buy
53
+35
+194% +$14.1K ﹤0.01% 7236
2018
Q4 		$6K Sell
18
-25
-58% -$19.4K ﹤0.01% 7325
2018
Q3 		$50K Buy
43
+16
+59% +$14.7K ﹤0.01% 6521
2018
Q2 		$23K Buy
27
+24
+800% +$19.9K ﹤0.01% 6857
2018
Q1 		$4K Buy
+3
New +$3.32K ﹤0.01% 7268
2017
Q4 		– Sell
-38
Closed -$41K – 7698
2017
Q3 		$41K Sell
38
-147
-79% -$167K ﹤0.01% 6102
2017
Q2 		$213K Buy
185
+49
+36% +$59.6K ﹤0.01% 4738
2017
Q1 		$156K Sell
136
-29
-18% -$28K ﹤0.01% 4867
2016
Q4 		$173K Buy
165
+158
+2,257% +$71.7K ﹤0.01% 5400
2016
Q3 		$3K Sell
7
-12
-63% -$4.89K ﹤0.01% 6887
2016
Q2 		$8K Sell
19
-6
-24% -$2.94K ﹤0.01% 6659
2016
Q1 		$10K Buy
25
+21
+525% +$8.12K ﹤0.01% 6813
2015
Q4 		$2K Buy
+4
New +$2.8K ﹤0.01% 7303
2015
Q3 		– Sell
-5
Closed -$5K – 7867
2015
Q2 		$5K Buy
+5
New +$5.86K ﹤0.01% 6792

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's HSTO Position: Q3 2021 in Review

Citigroup sold out of Histogen Inc. Common Stock (HSTO) in Q3 2021, closing a stake of 5 shares.

Citigroup first reported a position in HSTO in Q4 2013 and held it in 28 quarters. The position peaked at $703K in Q3 2015. 22 funds tracked by Wall St. Rank hold HSTO as of Q3 2021.

  • Citigroup reported no remaining Histogen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 5 Histogen Inc. Common Stock shares in Q3 2021.
  • Citigroup first reported a position in Histogen Inc. Common Stock in Q4 2013 and held it in 28 quarters.
  • Citigroup's Histogen Inc. Common Stock position peaked at $703K in Q3 2015.
  • 22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.